Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape

Nature(2021)10.1038/s41586-021-04005-0Source: DataRank Database

High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape is a research paper published in Nature (2021). On theSindex it has a DataRank of 0. It has been cited 240 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access240 citations

Download PDF

Cite:

Linked data & code

gen pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)Impact (FWCI 12.93)OA: bronzeTopics (56)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Yiska Weisblum ORCID,Magdalena Rutkowska ORCID,Daniel Poston ORCID,Justin DaSilva ORCID,Fengwen Zhang ORCID

Live enrichment

PubMed:34544114 PMC:PMC9241107 OpenAlex:https://openalex.org/W3199620752

NIH HHS

Grant: 2U19 AI111825

NIAID NIH HHS

Grant: R01 AI050111

NCATS NIH HHS

Grant: UL1 TR001866

NIAID NIH HHS

Grant: R01 AI078788

NIAID NIH HHS

Grant: F30 AI157898

NIGMS NIH HHS

Grant: T32 GM007739

NIAID NIH HHS

Grant: R37 AI064003

NIAID NIH HHS

Grant: U19 AI111825

National Institutes of Health

Grant: 5T32GM007739-30

Weill Cornell/Rockefeller/Sloan-Kettering MST Program

National Institutes of Health

Grant: 5UL1TR001866-07

Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success

National Institutes of Health

Grant: 5U19AI111825-02

Modulation of Human Dendritic Cell Development by Adjuvants and Vaccines

National Institutes of Health

Grant: 5R01AI064003-02

Retrovirus Restriction by Trima5alpha

National Institutes of Health

Grant: 2R01AI078788-12A1

Overcoming Host Restriction Factors to Develop Better Animal Models for HIV/AIDS

National Institutes of Health

Grant: 5F30AI157898-02

Elucidating antiviral defenses against diverse immunodeficiency viruses using a novel, high-throughput CRISPR/Cas9 screening method.

National Institutes of Health

Grant: 5R37AI064003-10

Discovery and Mechanism of Antiretroviral Factors

Howard Hughes Medical Institute

FWCI

12.93

Citation Percentile

1.0%

Citation Trend

2013

2014

2015

2017

2018

2021

2022

2023

2024

2025

2026

bronzeLicense: Springer TDM

journalhttps://www.nature.com/articles/s41586-021-04005-0.pdf

publisherhttps://www.nature.com/articles/s41586-021-04005-0.pdf

journalhttps://doi.org/10.1038/s41586-021-04005-0

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34544114

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9241107

Fields of Study

SARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologyAnimal Virus Infections StudiesAntibodies, NeutralizingAntibodies, ViralCOVID-19ConvalescenceCross ReactionsHumansImmune EvasionImmune SeraMutationNeutralization TestsSARS-CoV-2Spike Glycoprotein, CoronavirusSARS-CoV-2 variants

MeSH Terms

COVID-19SARS-CoV-2Antibodies, ViralConvalescenceCross ReactionsHumansImmune SeraMutationNeutralization TestsImmune EvasionAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

VirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Neutralizing antibodyCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakNeutralizationAntibodyImmune escapePolyclonal antibodiesBiologyGeneticsMedicineVirusImmune systemInfectious disease (medical specialty)OutbreakNeutralization TestsSARS-CoV-2Immune SeraMutationSpike Glycoprotein, CoronavirusCOVID-19HumansConvalescenceCross ReactionsAntibodies, ViralAntibodies, NeutralizingImmune Evasion

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era

10.6084/m9.figshare.21069579.v1figshare

Additional file 1 of SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era

10.6084/m9.figshare.21069579figshare